New Info On Paxlovid Confirms January 2022 3-Part Series Warning – The Washington Standard

If you recall in January of this year, Sons of Liberty Media carried a three-part series on Pfizer’s oral drug to combat covid-19 called Paxlovid (see here, here, and here), which received emergency use authorization (EUA) in December 2021. Warnings were issued on the drug-drug interactions, the adverse events associated …